A first-in-human study of the anti-LAG-3 antibody favezelimab plus pembrolizumab in previously treated, advanced microsatellite stable colorectal cancer

E. Garralda, A. Sukari, N. J. Lakhani, A. Patnaik, Y. Lou, S. A. Im, T. Golan, R. Geva, M. Wermke, M. de Miguel, J. Palcza, S. Jha, M. Chaney, A. K. Abraham, J. Healy, G. S. Falchook

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'A first-in-human study of the anti-LAG-3 antibody favezelimab plus pembrolizumab in previously treated, advanced microsatellite stable colorectal cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences